ImmunoGen Inc.

NASDAQ: IMGN · Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM

ImmunoGen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
275.14M 275.14M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
59.19M 59.19M
Receivables
17.98M 17.98M
Inventory
-28.98M 16.2M
Other Current Assets
11.01M 11.01M
Total Current Assets
275.14M 275.14M
Property-Plant & Equipment
14.61M 14.61M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
73.8M 73.8M
Total Assets
348.94M 348.94M
Account Payables
45.35M 45.35M
Deferred Revenue
13.86M 13.86M
Short-Term Debt
4.1M 4.1M
Other Current Liabilities
58.55M 37.64M
Total Current Liabilities
121.86M 121.86M
Long-Term Debt
11.15M 11.15M
Other Long-Term Liabilities
34.9M 51.73M
Total Long-Term Liabilities
71.25M 71.25M
Total Liabilities
193.11M 193.11M
Total Debt
15.24M 15.24M
Common Stock
2.26M 2.26M
Retained Earnings
-1.69B -1.69B
Comprehensive Income
1.85B 1.8B
Shareholders Equity
155.83M 155.83M
Total Investments
n/a n/a